Abstract
Ischemic cerebrovascular disease (ICVD) is a multifactorial disease caused by the interactions of several genetic and environmental factors. Tobacco smoke is a major cause of both cancer and vascular disease. Although its carcinogenic role via induction of DNA damage and mutation is well established, the mechanisms involved in vascular disease remain unclear. One possibility is that DNA damage causes smooth muscle cell proliferation in the intima of arteries, thereby contributing to atherothrombotic processes. The binding of chemicals to DNA is modulated by detoxification enzymes, including glutathione S-transferase (GST). We examined whether polymorphisms in this gene, as well as the angiotensin-converting enzyme (ACE) gene influence the risk of ICVD on smoking status. DNA was analyzed for deletions in the GST M1, T1, and ACE genes by polymerase chain reaction (PCR). No significant association was observed between GST null genotype and ICVD, even in smokers. However, a significant association between ACE and ICVD was observed only in smokers (X 2=0.023, p<0.05). We conclude that GST polymorphism is not a risk factor for the development of ICVD through smoking and suggest a high probability that ACE polymorphism may contribute to the odds of ICVD in smokers.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abdel-Rahman S. Z., El-zein R. A., Anwar W. A., and Au W. W. (1996) A multiplex PCR procedure for polymorphic analysis of GSTM1 and GSTT1 genes in population studies. Cancer Lett. 107, 229–233.
Bell D. A., Taylor J. A., Paulson D. F., Robertson C. N., Mohler J. L., and Lucier G. W. (1993) Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J. Natl. Cancer Inst. 85, 1159–1164.
Bridges B. A., Bowyer D. E., Hansen E. S., Penn A., and Wakabayashi K. (1990) The possible involvement of somatic mutations in the development of atherosclerotic plaques. Report of ICPEMC Subcommittee 7/1. Conclusions and recommendations. Mutat. Res. 239, 143–148.
Cambien F., Poirier O., Lecerf L., Evans A., Cambou J. P., Arveiler D., et al. (1992) Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359, 641–644.
Catto A., Carter A. M., Barrett J. H., Stickland M., Bamford J., Davies J. A., et al. (1996) Angiotensin-converting enzyme insertion/deletion polymorphism and cerebrovascular disease. Stroke 27, 435–440.
Chen C. L., Liu Q., and Relling M. V. (1996) Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks. Pharmacogenetics 6, 187–191.
Costerousse O., Allegrini J., Lopez M., and Alhenc-Gelas F. (1993) Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem. J. 290 (Pt 1), 33–40.
Danser A. H., Schalekamp M. A., Bax W. A., van den Brink A. M., Saxena P. R., Riegger G. A., et al. (1995) Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 92(6), 1387–1338.
De Flora S., Izzotti A., Walsh D., Degan P., Petrilli G. L., and Lewtas J. (1997) Molecular epidemiology of atherosclerosis. FASEB J. 11, 1021–1031.
Evans A. E., Poirier O., Kee F., Lecerf L., McCrum E., Falconer T., et al. (1994) Polymorphisms of the angiotensin-converting enzyme gene in subjects who die from coronary heart disease. Q. J. Med. 87, 211–214.
Hallier E., Langhof T., Dannappel M., Leutbecher M., Schroder K., Goergens H. W., et al. (1993) Polymorphism of glutathione conjugation of methyl bromide, ethylene oxide and dichloromethane in human blood: influence on the induction of sister chromatid exchanges (SCE) in lymphocytes. Arch. Toxicol. 67, 173–178.
Hemminki K., Dipple A., Shuker D. E. G., Kadlubar F. F., Segerback D., and Bartsch H. (1994) DNA adducts: identification and biological significance, IARC Scientific Publications, no. 125, Huddinge, Sweden.
Jeunemaitre X., Soubrier F., Kotelevtsev Y. V., Lifton R. P., Williams C. S., Charru A., et al. (1992) Molecular basis of human hypertension: role of angiotensinogen. Cell 71, 169–180.
Kario K., Kanai N., Saito K., Nago N., Matsuo T., and Shimada K. (1996) Ischemic stroke and the gene for angiotensin-converting enzyme in Japanese hypertensives. Circulation 93, 1630–1633.
Miller S. A., Dykes D. D., and Polesky H. F. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16, 1215.
Murata M., Watanabe M., Yamanaka M., Kubota Y., Ito H., Nagao M., et al. (2001) Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population. Cancer Lett. 165(2), 171–177.
Nelson H. H., Wiencke J. K., Christiani D. C., Cheng, T. J., Zuo Z. F., Schwartz B. S., et al. (1995) Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. Carciogenesis 16, 1243–1245.
Penn A. and Snyder C. A. (1988) Arteriosclerotic plaque development is ‘promoted’ by polynuclear aromatic hydrocarbons. Carcinogenesis 9, 2185–2189.
Penn A. and Snyder C. A. (1996) 1,3-Butadiene, a vapor phase component of environmental tobacco smoke, accelerates arteriosclerotic plaque. Circulation 93, 552–557.
Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., and Soubrier F. (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 86, 1343–1346.
Ross R. (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 801–809.
Samuni N. J., Thompson J. R., O’Toole L., Channer K., and Woods K. L. (1996) A meta-analysis of the association of deletion allele of the angiotensin converting enzyme gene with myocardial infarction. Circulation 94, 708–712.
Seino Y., Ikeda U., Maeda Y., Haga Y., Yashima H., and Shimada K. (1998) Angiotensin-converting enzyme gene polymorphism and plasminogen activator inhibitor 1 levels in subjects with cerebral infarction. J. Thromb. Thrombolysis 5, 263–267.
Sharma P. (1996) Genes for ischameic stroke: strategies for their detection. J. Hyperten. 14, 277–285.
Sharma P., Carter N. D., Barley J., and Brown M. M. (1994) Molecular approach to assessing the genetic risk of cerebral infarction: deletion polymorphism in the gene encoding angiotensin I-converting enzyme. J. Hum. Hypertens. 8, 645–648.
Strange R. C., Jones P. W., and Fryer A. A. (2000) Glutathione S-transferase: genetics and role in toxicology. Toxicol. Lett. 112–113, 357–363.
Taningher M., Malacarne D., Izzotti A., Ugolini D., and Parodi S. (1999) Drug metabolism polymorphisms as modulators of cancer susceptibility. Mutat. Res. 436, 227–261.
Um J. Y., Kim H. J., Choi T. J., Jin C. S., Park S. T., Lee K. C., et al. (2001) Polymorphism of the angiotensin-converting enzyme gene in patients with cerebral infarction in Koreans. J. Mol. Neurosci. 17, 15–19.
Wilson M. H., Grant P. J., Hardie L. J., and Wild C. P. (2000) Glutathione S-transferase M1 null genotype is associated with a decreased risk of myocardial infarction. FASEB. J. 14(5), 791–796.
Yim J. J., Park G. Y., Lee C. T., Kim Y. W., Han S. K., Shim Y. S., et al. (2000) Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1. Thorax 55(2), 121–125.
Zhao Y., Higashimori K., and Higaki J. (1994) Significance of the deletion polymorphism of the angiotensin converting enzyme gene as a risk factor for myocardial infarction in Japanese. Hypertens. Res. 17, 55–57.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Um, JY., An, NH., Kim, SH. et al. Genetic susceptibility to ischemic cerebrovascular disease in Koreans. J Mol Neurosci 20, 31–38 (2003). https://doi.org/10.1385/JMN:20:1:31
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/JMN:20:1:31